Excited to kick off the new academic year with a commitment to hindsight, insight, and foresight. Thanks to CAS for the inspiration 💙🩵💛

Perfect CAS bag for guitar pedals CAS🥳

Did you miss our CAS STNext webinar on the Derwent Chemistry Resource (DCR) database? Watch the recording and learn how to execute a comprehensive #research strategy: ow.ly/Ga0z50TeC7G

Do you know how to establish a robust #patent monitoring program? Listen to Part 2 of our podcast with Managing IP to get all the details from CAS #IP experts Matt Garver and Peter Mattei. ow.ly/iPxr50SK7FZ

How can we produce sufficient energy and reduce #GreenhouseGas emissions? #CarbonNanotubes may be the answer by transforming energy storage methods like batteries. Get the full picture: ow.ly/eZkH50SPu6l #EnergyStorage

Shorten research time with CAS Analytical Methods, an unparalleled resource that makes it simple to locate, compare, and understand analytical methods from top journals and patents. ​Learn more: ow.ly/LNtP50QIohe

Don't forget to join us for our "CAS SciFinder Live: What’s New and Upcoming" webinar later this week. Stay current on the latest enhancements in CAS SciFinder, see how they improve existing workflows, and ask questions specific to your own research. ow.ly/qH4950SIFIM

Thank you to the 2024 #CASFutureLeaders for bringing so much energy and excitement to our headquarters and #ACSFall2024 this past August. We’re excited to watch this group of exceptional early-career scientists continue their leadership journeys in the years ahead!

The #CASFutureLeaders program was an extraordinary experience. But, what will stay with me most, however, is the lasting friendship I made with this remarkable group. The program far exceeded my expectations, and I am so grateful to have been selected for the 2024 cohort.

Still can't believe I got to join the 2024 #CASFutureLeaders program and meet these amazing people! Definitely one of the best experiences in my graduate career ❤️ If you're hesitant about applying next year, I'll make it easy: DO IT! Mama G said so...

It was an honour to participate in the #CASFutureLeaders programme again, but this time as a speaker! At Agata Communications we built a bespoke #scicomm course about storytelling, writing, and a bit of PR – I think it was a blast ✨ Thanks Peter Carlton for the opportunity 💖

Rare diseases have been misdiagnosed and under-researched for years. However, company and researcher interest has rapidly grown. See the current landscape in this Insights report. ow.ly/tXq150SQkEj #MedicalResearch #HealthcareTrends

Genetic and cell therapies offer exciting new opportunities for treating #RareDiseases. These therapies use the body’s own proteins to address dysfunctional processes, and they’re making strides against ALS, Huntington’s and other hard-to-treat diseases. ow.ly/hIsc50SQhjU

Are you attending the Analytica Anacon India and India Lab Expo 2024? Visit us at booth A05 to learn how CAS SciFinder and CAS BioFinder can support your workflows. ow.ly/j3Y850SuPvj #AnalyticaAnaconIndia

Don’t forget to register for our CAS STNext Coffee Lecture on Sept. 11! Learn how to retrieve property data in the REAXYSFILE database efficiently. ow.ly/KmV050T5kqK

Catch up on our #biomaterials webinar, where experts talked about how their unique applications have diverse medicinal properties. Check out the full recap: ow.ly/BIVT50T1uHA

If you’re attending Discovery on Target this year, then meet us at booth 314! Learn how CAS Custom Services can create a tailored solution for your #datamanagement. ow.ly/zJni50SuST8 Cambridge Healthtech Institute

Do you know how to use #toxicology data in your CAS STNext searches? Attend our upcoming webinar on Sept. 25 to learn how. ow.ly/Sf0i50TkafS

Fines and delivery delays should not be part of your business plan. Stay ahead and remain compliant with CAS Chemical Compliance Index.​ ow.ly/bi8Z50QAMhk

Current treatment for #autoimmune diseases involves suppressing the immune system, but it leaves patients open to infection. Researchers are finding ways to teach the body to stop attacking its own cells. Read more in our #CASInsights article: ow.ly/UUuM50Sjck8